Startups
Rely on Novocell for buying HGH online and learn best practices to make informed decisions. Read the full guide here for essential insights!
Overview
Location
United States
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 20, 2007 | Novocell: With diabetes study pending, investors pony up another $25M | Novocell, a San Diego embryonic stem-cell company, raised $25 million in a third round of funding. That’s presumably a bit of a letdown for the company, which had previously hoped to pull in as much as $35 million in the round. I wrote earl... |
| Jul 17, 2007 | Novocell Raises $25M | San Diego-based Novocell said Monday that it has closed on $25M in Series C financing. The round came from Sanderling Ventures, Asset Management Company, Pacific Horizon Ventures, and Johnson & Johnson Development Corporation. Johnson &... |
| Apr 6, 2007 | Is Big Pharma tiptoeing into embryonic stem cells? | (Note: This item has been copied over to the Life Sciences page from its original location on the VentureBeat main page. To view it in its original context, with comments, click here.) For what appears to be the first time, a major drug com... |
| Apr 6, 2007 | Is Big Pharma tiptoeing into embryonic stem cells? | For what appears to be the first time, a major drug company has plunked down a significant equity investment in embryonic stem cells. Earlier today, VentureWire reported (sub required) that Novocell, an early-stage San Diego biotech that ai... |
| Apr 3, 2007 | Chinks in the stem-cell monopoly | The U.S. patent office has invalidated some key stem-cell patents, a significant move that could shake up a potentially huge market for embryonic stem-cell therapies that may one day restore all kinds of body parts for the sick and injured.... |
| Apr 3, 2007 | Chinks in the stem-cell monopoly | (Note: This item has been copied over to the Life Sciences page from its original location on the VentureBeat main page. To view it in its original context, with comments, click here.) The U.S. patent office has invalidated some key stem-ce... |